Edition:
United Kingdom

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

6.56USD
19 Jun 2019
Change (% chg)

-- (--)
Prev Close
$6.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
32,280
52-wk High
$14.90
52-wk Low
$5.86

About

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads... (more)

Overall

Beta: -0.59
Market Cap(Mil.): $173.02
Shares Outstanding(Mil.): 28.13
Dividend: --
Yield (%): --

Financials

  CTSO.OQ Industry Sector
P/E (TTM): -- 191.94 32.55
EPS (TTM): -0.37 -- --
ROI: -77.87 9.69 13.82
ROE: -162.40 15.57 15.24

Earnings vs. Estimates